Cipla seeks price hike of asthma drugs citing 300 percent rise in production cost, writes to NPPA Medical Dialogues Team8 Sept 2021 3:01 PM ISTNew Delhi: Citing a 300 percent rise in the price of propellant P227, a critical ingredient used in respiratory formulation, Cipla has written to the...
How to safely perform surgery during COVID-19 pandemic: Study MD Editorial Team8 Sept 2021 9:00 AM ISTA recent study by researchers from Turkey brought out that patients with gastrointestinal cancer should be operated on in pandemic hospitals under...
Cipla gets CDSCO panel nod for BE study of idiopathic pulmonary fibrosis drug Pirfenidone Medical Dialogues Team7 Sept 2021 2:59 PM ISTNew Delhi: Pharmaceutical major, Cipla has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization...
Zydus Cadila ZyCov-D to seek CDSCO nod for two-dose regimen: Report Medical Dialogues Team6 Sept 2021 6:07 PM ISTNew Delhi: After the the Drug Controller General of India (DCGI) Emergency Use Authorisation (EUA) for the needle-free 3-dose Covid-19 vaccine...
NPPA panel nod to15 percent hike in price of Otsuka Pharma 3 formulations Medical Dialogues Team5 Sept 2021 11:30 AM ISTNew Delhi: In response to Otsuka Pharmaceutical's application for a separate price, the National Pharmaceutical Pricing Authority (NPPA) has approved...
Govt adds 39 drugs in NLEM, NPPA to do final price cap Medical Dialogues Team4 Sept 2021 5:21 PM ISTNew Delhi: The Union government has revised the National List of Essential Medicines (NLEM) by adding 39 new drugs under the list for proposed price...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Aristo Pharma Medical Dialogues Team3 Sept 2021 6:24 PM ISTNew Delhi: Giving the benefits of patent expiry of popular antidiabetic drug, the National Pharmaceutical Pricing Authority (NPPA) panel has set the...
CDSCO asks drugmakers to market Tolperisone, Paracetamol FDC solely for revised indication Medical Dialogues Team2 Sept 2021 4:45 PM ISTNew Delhi: The Central Drugs Standard Control Organization (CDSCO) has directed all State and Union Territory (UT) drug controllers to instruct all...
IPC flags adverse reaction linked to Hepatitis C drug Sofosbuvir Medical Dialogues Team1 Sept 2021 2:13 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC) has recently issued a drug safety alert for the month of August, revealing that the antiviral...
NPPA panel fixes retail price of Vildagliptin, Metformin FDCs marketed by Aristo Pharma Medical Dialogues Team31 Aug 2021 5:55 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the popular antidiabetic Fixed-Dose Combination (FDC)...
NPPA panel to examine price of antibacterial FDC Cefixime, Lactic Acid Bacillus Medical Dialogues Team30 Aug 2021 4:10 PM ISTNew Delhi: Holding that unreasonably higher price due to the addition of Lactic acid bacillus to the scheduled formulation of Cefixime 200 mg tablet...
Regularization of 31 FDCs declared rational: Drugmakers told to submit application within 6 months Medical Dialogues Team29 Aug 2021 11:15 AM ISTNew Delhi: In order to regularize Fixed Dose Combinations (FDCs) declared rational by the DTAB in respect of 294 FDCs, the Central Drugs Standard...
